TG Therapeutics | TGTX - SCHULD

Aktienkurs
33.73
Täglich Wechseln
-0.90 -2.60%
Monatlich
20.25%
Jährlich
-8.12%
Q2 Prognose
32.81




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.59B 1.62B 2025-09
Ardelyx USD 207.61M 968K 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.29B 1.7M 2025-12
Corcept Therapeutics USD 6.36M 247K 2025-09
Curis USD 0 0 2022-06
Gilead Sciences USD 24.94B 5M 2025-09
Infinity Pharmaceuticals USD 0 0 2022-06
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 32.64B 1.37B 2025-06
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 245.34M 8.38M 2025-09
Verastem USD 66.79M 26.7M 2024-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09